Témata

• Understanding causative mechanisms in co- and multimorbidities
• International flagship collaboration with Canada for human data storage, integration and sharing to enable personalised medicine approaches
• Exploiting research outcomes and application potential of the human microbiome for personalised prediction, prevention and treatment of disease
• Regenerative medicine: from new insights to new applications
• Systems approaches for the discovery of combinatorial therapies for complex disorders
• Rare Disease European Joint Programme Cofund
• Innovation platforms for advanced therapies of the future
• Stratified host-directed approaches to improve prevention, treatment and/or cure of infectious diseases
• Mining big data for early detection of infectious disease threats driven by climate change and other factors
• Innovation Procurement: Next generation sequencing (NGS) for routine diagnosis
• Implementation research for maternal and child health
• Mental health in the workplace
• Global Alliance for Chronic Diseases (GACD) - Scaling-up of evidence-based health interventions at population level for the prevention and management of hypertension and/or diabetes
• The Human Exposome Project: a toolbox for assessing and addressing the impact of environment on health
• Demonstration pilots for implementation of personalised medicine in healthcare
• New testing and screening methods to identify endocrine disrupting chemicals
• Data integration and data-driven in-silico models for enabling personalised medicine - a European standardization framework
• ERA-NET to support the Joint Programming in Neurodegenerative Diseases strategic plan (JPND)
• Establishment of an International Network of Social Sciences Research Centres to help address governance and other challenges in the preparedness for and the response to infectious threats
• Strengthening regulatory sciences and supporting regulatory scientific advice
• Building international efforts on population and patient cohorts
• Coordinating European brain research and developing global initiatives
• Actions in support of the International Consortium for Personalised Medicine
• Creation of a European wide sustainable clinical research network for infectious diseases
• Strategic collaboration in health research and innovation between EU and China
• Innovation in healthcare - a CSA towards using pre-commercial procurement and public procurement of innovative solutions in healthcare systems
• Setting the priorities for a European environment, climate and health research agenda
• HTA research to support evidence-based healthcare
• New anti-infective agents for prevention and/or treatment of neglected infectious diseases (NID)
• Novel patient-centred approaches for survivorship, palliation and/or end-of-life care
• Research on HIV, tuberculosis (TB) and/or hepatitis C (HCV) in patients with mono-, co-infections and/or comorbidities in the context of fostering collaboration with the Russian Federation
• Translational collaborative cancer research between Europe and the Community of Latin American and Caribbean States (CELAC)
• Pilot actions to build the foundations of a human cell atlas
• Towards risk-based screening strategies for non-communicable diseases
• Towards a next generation influenza vaccine to protect citizens worldwide – an EU-India collaboration
• Support for the functioning of the Global Research Collaboration for Infectious Disease Preparedness (GloPID-R)
• Digital diagnostics – developing tools for supporting clinical decisions by integrating various diagnostic data
• New interventions for Non-Communicable Diseases
• Addressing low vaccine uptake
• Advancing the safety assessment of chemicals without the use of animal testing
• Global Alliance for Chronic Diseases (GACD) - Prevention and/or early diagnosis of cancer
• Pre-commercial procurement (PCP) for integrated care solutions
• Public procurement of innovative solutions (PPI) for diagnostics for infectious diseases
• Healthcare interventions for the management of the elderly multimorbid patient
• Innovative actions for improving urban health and wellbeing - addressing environment, climate and socioeconomic factors
• New approaches for clinical management and prevention of resistant bacterial infections in high prevalence settings
• Creation of a European wide sustainable network for harmonised large-scale clinical research studies for infectious diseases
• Micro- and nano-plastics in our environment: Understanding exposures and impacts on human health
• Towards the new generation of clinical trials – trials methodology research
• Use of Real-World Data to advance research on the management of complex chronic conditions
• Implementation research for scaling up and transfer of innovative solutions involving digital tools for people-centred care
• Towards a Health research and innovation Cloud: Capitalising on data sharing initiatives in health research
• Bridging the divide in health research and innovation – boosting return on investment
• ERA-NET to support the Joint Programming Initiative on Antimicrobial resistance (JPIAMR)
• ERA-NET: Sustained collaboration of national and regional programmes in cancer research
• ERA-NET: Sustained collaboration of national and regional programmes in research on brain-related diseases and disorders of the nervous system
• Coordinating and supporting research on the human microbiome in Europe and beyond
• Developing methodological approaches for improved clinical investigation and evaluation of high-risk medical devices
• Reliable and accessible information on cell and gene-based therapies
• Coordination of clinical research activities of the European Reference Networks